Efficacy and Safety of Corticosteroids in COVID-19

NACompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

February 14, 2020

Primary Completion Date

April 15, 2020

Study Completion Date

April 15, 2020

Conditions
COVID-19Novel Coronavirus Pneumonia
Interventions
DRUG

Methylprednisolone

Methylprednisolone 1mg/kg/day ivgtt for 7 days.

Trial Locations (7)

Unknown

Hubei province hospital of integrated Chinese & Western Medicine, Wuhan

Yichang first people's Hospital, Yichang

Beijing YouAn Hospital, Beijing

Renmin Hospital of Wuhan University, Wuhan

Tianyou Hospital Affiliated to Wuhan University of science and technology, Wuhan

Union Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology, Wuhan

the first peopel hospital of Xiangyang, Xiangyang

All Listed Sponsors
lead

Beijing Chao Yang Hospital

OTHER

NCT04273321 - Efficacy and Safety of Corticosteroids in COVID-19 | Biotech Hunter | Biotech Hunter